Metraipolis › archive › dc_759f45be0eeb

Using ctDNA to Inform Adjuvant Therapy for Urologic Malignancies — Europe PMC PMID:41976347

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41976347
DOI
10.3390/cancers18071121
License (as archived)
solo-consultazione
Archived
2026-11-03T15:09:44.112Z
SHA-256 of the archived text
47dc108d6f64fbac43e2a0e429c236fbed06f2a135925014fa288d2d4539b0e4
Stable URL of this page
https://metraipolis.com/documento/dc_759f45be0eeb

How to cite

Using ctDNA to Inform Adjuvant Therapy for Urologic Malignancies — Europe PMC PMID:41976347 — Europe PMC (en), https://europepmc.org/article/MED/41976347 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_759f45be0eeb (Metraipolis archive dc_759f45be0eeb, sha256 47dc108d6f64fbac43e2a0e429c236fbed06f2a135925014fa288d2d4539b0e4)
BibTeX
@misc{dc759f45be0eeb,
  title = {Using ctDNA to Inform Adjuvant Therapy for Urologic Malignancies — Europe PMC PMID:41976347},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41976347},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_759f45be0eeb; sha256 47dc108d6f64fbac43e2a0e429c236fbed06f2a135925014fa288d2d4539b0e4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41976347. Agents can read the archived copy with the MCP tool read_document.